19.06.2019 • NewsChristian KohlpaintnerClariantPeople

Christian Kohlpaintner to Leave Clariant

Christian Kohlpaintner, member of Clariant’s executive committee, decided to...
Christian Kohlpaintner, member of Clariant’s executive committee, decided to resign from his position effective June 30, 2019. Source: Clariant

Swiss specialty chemical company Clariant announced that Christian Kohlpaintner, who is a member of the company’s executive committee, decided to resign from his position effective June 30, 2019.

Kohlpaintner led the business units Care Chemicals, Catalysis and Natural Resources and was accountable for the regions Greater China, India, Japan, and South East Asia & Pacific. In addition, he was responsible for Group Technology & Innovation and Corporate Sustainability & Regulatory Affairs.

“We very much regret the decision of Christian Kohlpaintner to leave Clariant”, said Hariolf Kottmann, chairman of Clariant’s board of directors. “He made significant contributions to shaping the company into the leading specialty chemicals player it is today. From business turnarounds and acquisitions to innovations, he has created substantial value for Clariant over the past 10 years. It is largely thanks to him that Clariant is inextricably linked to topics such as sustainability, innovation and our China growth strategy. We wish him all the best for his future endeavors.”

For the time being, Kohlpaintner’s responsibilities will be assumed by the remaining members of the executive committee, the company said.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.